Francesca Wirth

Suggest Changes
  • Citations Per Year
Learn More
Background A quick CYP2C19*2 genotyping assay can be useful in personalised antiplatelet-therapy. Objective To apply a rapid point-of-care (POC) CYP2C19*2 genotyping assay for personalisation of(More)
Background Atrial fibrillation (AF) is highly prevalent in older persons and is associated with considerable morbidity and mortality. Assessing appropriateness of drug therapy in AF may be(More)
Nordic Social Pharmacy and Health Services Research Conference & The Nordic Networking Group of Clinical Pharmacy June 3–5, 2015, Tartu, Estonia Published online: 23 April 2015 Koninklijke(More)
  • 1